yv reddy : Latest News, Videos and Photos | Outlook Business
Home » Search
Search Result : "yv reddy"

The general manager of Four Seasons, Mumbai on why the Macallan is his favourite whisky

Dr Reddy's is adapting to industry dynamics and seizing opportunities while staying true to the founder’s vision

Now that Apollo Hospitals’ aggressive capex is done, analysts believe it is time to buy the stock

Ditch those access cards and entry registers. You could soon be entering your home, workplace and even hotel rooms with just your smartphone

They are champions in their domain, leaders and entrepreneurs shaped out of pure grit and unconventional ideas

Despite promoters — BVR Mohan Reddy and Krishna Bodanapu's — effort to arrest the fall in Cyient’s stock, investors remain jittery over weak guidance

Indian pharma majors are facing their toughest year yet in the US, with regulatory clampdown, hostile political environment and falling prices. Is reinvention the answer to their woes?

Generic Indian pharma players are changing their formula to focus on high-margin complex generics and specialty drugs

Quick adaptability and consistency have turned TeamLease into a Rs.40-billion company and one of the largest workforce outsourcing firms in India

This healthcare app hopes to bridge the distance between patients and doctors, through real-time info sharing

Edelweiss Securities' head of research sees huge potential in Dr Reddy's, and also an attractive valuation 

In Ankleshwar, feisty MSMEs that survived the Chinese onslaught say that the fight against red tapism is harder

Q1FY19 has logged GDP growth of 8.2%, kindling hopes of an economic revival

If machines can talk to each other, why can’t academia and industry, asks DRDO’s Satheesh Reddy 

Dr Reddy’s promoter GV Prasad buys in the open market amid growing headwind

A strong product pipeline and receding US FDA threat could well turn the tide in favour of the beleaguered pharma players

What makes Intas the most valuable privately-held pharma company in India

Vishnukant Bhutada’s big bet on oncology has catapulted Shilpa Medicare into the global generics space

The domestic pharma industry, which is already battling the US FDA, has now to contend with regulatory challenges at home

Gunupati Venkata Krishna Reddy of GVK Group, begins his day by sweating it out on the tennis court

Companies are eyeing buybacks to enhance shareholder value, save tax and deploy surplus cash

Hyderabad’s pharma players are adapting to a regulatory backlash and fighting back against dumping from China

After a dream run, Sun Pharma is grappling with growth and regulatory issues. Can the country’s biggest drug maker rediscover its mojo?